Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13
Article in Journal of Medical Economics (April 2024)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Article in Journal of Medical Economics (April 2024)
Article in Emerging Infectious Diseases (March 2024)
Article in Vaccines (January 2024)